Novo Nordisk: against COVID-19 ^Company

Entity: Novo Nordisk

Category: Treatment Development

Description: Novo Nordisk is a healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given them experience and capabilities that also enable them to help people defeat other serious chronic conditions like haemophilia, growth disorders and obesity.

Project: Helpline with investments from NHS

Summary: Novo Nordisk worked with the NHS on new helpline which has now been launched to support people with diabetes during the COVID-19 outbreak. The initiative came from discussions and collaboration between NHS England, Diabetes UK and Novo Nordisk, including Novo Nordisk Diabetes Specialist Nurses. In March, Novo Nordisk worked closely with NHS England and Diabetes UK to develop and set up the helpline to advise those who need help with insulin. The company is supporting the helpline with volunteering diabetes specialist nurses’ time and expertise, as well as leading the coordination of the industry support. So far, the helpline has 18 volunteers from Novo Nordisk, working alongside others. More volunteers are joining over the next few weeks.